Research Topics
Genomes and Genes | Hanno HockSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cellsHanno Hock
Division of Hematology Oncology, Children s Hospital, Boston, Massachusetts 02115, USA
Nature 431:1002-7. 2004..Thus, Gfi-1 is essential to restrict HSC proliferation and to preserve HSC functional integrity...
A complex Polycomb issue: the two faces of EZH2 in cancerHanno Hock
Cancer Center, Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Genes Dev 26:751-5. 2012..Moreover, in concert with concurrent studies, the authors revealed that similar mechanisms are involved in human T-ALL. These data contrast with previous findings showing that increased EZH2 activity promotes cancer...
Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cellsHanno Hock
Division of Hematology Oncology, Children s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA
Curr Opin Hematol 13:1-6. 2006..Here we review recent studies pertaining to Gfi-1 and its cell context specific functions in hematopoietic development...
Some hematopoietic stem cells are more equal than othersHanno Hock
The Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
J Exp Med 207:1127-30. 2010..Several recent studies substantially refine our understanding of the cells at the very top of the hematopoietic hierarchy, and suggest that we may need to revise the criteria we typically use to identify and define HSCs...
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cellsAdlen Foudi
Cancer Center, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, USA
Nat Biotechnol 27:84-90. 2009..8-1.8% per day)...
Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 geneHanna K A Mikkola
Department of Pediatric Oncology, Children s Hospital and the Dana Farber Cancer Institute, Harvard Medical School and Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA
Nature 421:547-51. 2003..These findings contrast with lineage choice mechanisms, in which the identity of haematopoietic lineages requires continuous transcription factor expression...
TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemiaJeffrey W Schindler
Cancer Center, Massachusetts General Hospital, Boston, MA 02114, USA
Cell Stem Cell 5:43-53. 2009..Our work shows that stem cells are susceptible to subversion by weak oncogenes that can subtly alter their molecular program to provide a latent reservoir for the accumulation of further mutations...
Chromatin protein L3MBTL1 is dispensable for development and tumor suppression in miceJinzhong Qin
Cancer Center, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Biol Chem 285:27767-75. 2010..In cohorts of mice followed for more than 2 years, lack of L3MBTL1 did not alter normal lifespan or survival with or without sublethal irradiation...
Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cellsSarah Eminli
Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, Massachusetts, USA
Nat Genet 41:968-76. 2009..Moreover, we identify hematopoietic progenitors as an attractive cell type for applications of iPS cell technology in research and therapy...
Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiationHanno Hock
Division of Hematology Oncology, Children s Hospital, Harvard Medical School, Boston, MA 02115, USA
Immunity 18:109-20. 2003..Thus, Gfi-1 not only promotes differentiation of neutrophils but also antagonizes traits of the alternate monocyte/macrophage program...
Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survivalHanno Hock
Division of Hematology Oncology, Children s Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Genes Dev 18:2336-41. 2004..Thus, we establish Tel/Etv6 as a selective and essential regulator of postembryonic HSCs...
The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early developmentJinzhong Qin
Cancer Center, Massachusetts General Hospital, Boston, MA 02114, USA
Cell Stem Cell 11:319-32. 2012..However, some developmental regulators are repressed by the combined activity of all three complexes. Together, we have uncovered a highly selective, essential role for an atypical PRC1-family complex in ES cells and early development...
Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1Paul A Monach
Joslin Diabetes Center, Brigham and Women s Hospital, and Harvard Medical School, Boston, MA 02115, USA
Arthritis Rheum 62:753-64. 2010..In this study, we developed a system with which to test the importance of the production of specific factors by neutrophils in a mouse model of arthritis...
The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytesFan Mou
Department of Molecular Biology, Massachusetts GeneralHospital, Boston, MA 02114, USA
J Exp Med 209:741-59. 2012..Thus, the Mst1 and Mst2 kinases control Rho GTPase activation and the migratory responses of SP thymocytes...
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complexZhe Li
Division of Hematology Oncology, Children s Hospital Boston, Boston, MA 02115, USA
Cancer Cell 12:542-58. 2007..Given the increasing relevance of chromosomal translocations in epithelial cancers, such mice serve as a paradigm for the study of their genetic pathogenesis and cellular origins, and generation of preclinical models...
Stem cells: the road not takenHanno Hock
Nature 435:573-5. 2005
